학술논문
Minimal manifestation status and prednisone withdrawal in the MGTX trial
Document Type
Article
Author
Lee, I.; Kuo, H.-C.; Aban, I.B.; Cutter, G.R.; McPherson, T.; Minisman, G.; Kaminski, H.J.; Sussman, J.; Ströbel, P.; Oger, J.; Cea, G.; Heckmann, J.M.; Evoli, A.; Nix, W.; Ciafaloni, E.; Antonini, G.; Witoonpanich, R.; Chalk, C.H.; King, J.O.; Beydoun, S.R.; Barboi, A.C.; Amato, A.A.; Shaibani, A.I.; Katirji, B.; Lecky, B.R.F.; Buckley, C.; Vincent, A.; Dias-Tosta, E.; Yoshikawa, H.; Waddington-Cruz, M.; Pulley, M.T.; Rivner, M.H.; Kostera-Pruszczyk, A.; Pascuzzi, R.M.; Jackson, C.E.; Verschuuren, J.J.G.; Massey, J.M.; Kissel, J.T.; Werneck, L.C.; Benatar, M.; Barohn, R.J.; Tandan, R.; Mozaffar, T.; Conwit, R.; Sonett, J.R.; Wolfe, G.I.
Source
In: Neurology . (Neurology, 11 August 2020, 95(6):E755-E766)
Subject
Language
English
ISSN
1526632X
00283878
00283878